AcuCort AB
Develops a rapid oral film for acute allergies, croup, and chemo-induced nausea.
ACUC | SPGR
Overview
Corporate Details
- ISIN(s):
- SE0009695927
- LEI:
- 54930087FR3VVW5SU676
- Country:
- Sweden
- Address:
- Scheeletorget 1, 223 81 Lund
- Website:
- https://www.acucort.se/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
AcuCort AB is an innovative pharmaceutical company that develops and commercializes 'smart drugs'—improved, user-friendly treatments based on well-documented substances. The company's lead product is Zeqmelit®, a patented, rapidly dissolving oral film containing the cortisone dexamethasone. This novel dosage form is designed for the rapid and simple treatment of severe and acute allergic reactions, croup in children, and chemotherapy-induced nausea and vomiting. AcuCort's strategy focuses on enhancing patient convenience and addressing unmet medical needs through improved drug delivery. The company commercializes its products through a global network of licensees and distribution partners.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all AcuCort AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for AcuCort AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-24 | Ebba Cecilia Fåhraeus | Other | Buy | 91,000 | 81,900.00 SEK |
